Bruce Daggy

Bruce Daggy

Bruce Daggy, Senior Vice President, Research & Development and Chief Science Officer oversees and directs the functions of corporate research and development. He is primarily responsible for the development of Shaklee’s robust portfolio of products including nutrition, personal care, household, and environmental products of for the home.

His career spans over 30 years in global roles within consumer healthcare. In nutrition, his work has ranged from developing leading nutritional supplements in India to providing sports nutrition products to elite athletes. He also has had a major focus on weight management and metabolic disease. He began his professional career in academia and then spent 10 years in research and development at The Procter & Gamble Company. After P&G, Bruce spent over 13 years at SmithKline Beecham/Glaxo SmithKline in both the United States and the United Kingdom in various leadership positions, including overseeing their global nutritional research and development and managing over 80 scientists in the U.K. as well as a team in India. In addition, he was also the Vice President, Weight Control Research & Development for Glaxo SmithKline.

Prior to joining Shaklee, Bruce served as Senior Vice President, Research & Development and Chief Science Officer at Nutrisystem Inc. where he directed applied research and development for weight management and the prevention or management of obesity-related diseases and disorders.

Bruce has a Ph.D. in Nutritional Biochemistry from Cornell University and a B.A. in Biology from University of Virginia. He has authored 80 publications and abstracts and has developed 13 patents in his name. He serves as Adjunct Professor and Advisory Board Member within the Nutrition, Food, and Exercise Sciences Department of Florida State University. He is a member of the American Society for Nutrition and of The Obesity Society, and has been an active volunteer with the American Diabetes Association’s Greater Philadelphia Community Board and its Education and Advocacy Committee.

Leave a Reply

Open chat